Answers are grounded in this paper and cite their sources.
Investigates outcomes of transjugular intrahepatic portosystemic shunts for portal vein thrombosis in cirrhotic patients, suggesting improved transplant readiness.
The presence of portal vein thrombosis (PVT) in the pre-liver transplant patient can significantly impact waitlist, peri- and posttransplant outcomes, morbidity, and mortality. This article describes the pathophysiology of PVT and treatment options in patients with cirrhosis. It defines indications and rationale for placing transjugular intrahepatic portosystemic shunts, emphasizing technical details and risks in patients with nonneoplastic PVT awaiting liver transplantation.
No takes yet. Share an insight, caveat, or question.
Novelli et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: